

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.80923311 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 5.76309473 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 5.76309473 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.76309473 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.76309473 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.76309473 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.76309473 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.49201190 |
| 9 | positive regulation of monocyte chemotaxis (GO:0090026) | 5.44193867 |
| 10 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.18161189 |
| 11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.14573020 |
| 12 | positive regulation of interferon-alpha production (GO:0032727) | 5.10552566 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 5.05441086 |
| 14 | eosinophil chemotaxis (GO:0048245) | 5.04859750 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.99198899 |
| 16 | microglial cell activation (GO:0001774) | 4.98780539 |
| 17 | glycosphingolipid catabolic process (GO:0046479) | 4.95303610 |
| 18 | regulation of interferon-alpha production (GO:0032647) | 4.87251442 |
| 19 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.83419892 |
| 20 | positive regulation of antigen processing and presentation (GO:0002579) | 4.80806404 |
| 21 | macrophage activation (GO:0042116) | 4.56686229 |
| 22 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.54132253 |
| 23 | oligosaccharide catabolic process (GO:0009313) | 4.52682478 |
| 24 | glycolipid catabolic process (GO:0019377) | 4.45756293 |
| 25 | eosinophil migration (GO:0072677) | 4.44345626 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 4.39321087 |
| 27 | regulation of monocyte chemotaxis (GO:0090025) | 4.21125167 |
| 28 | response to peptidoglycan (GO:0032494) | 4.21086504 |
| 29 | regulation of antigen processing and presentation (GO:0002577) | 4.11068248 |
| 30 | amino sugar catabolic process (GO:0046348) | 4.09299927 |
| 31 | respiratory burst (GO:0045730) | 4.07776010 |
| 32 | regulation of mononuclear cell migration (GO:0071675) | 4.01939438 |
| 33 | granulocyte activation (GO:0036230) | 3.98117131 |
| 34 | neutrophil activation (GO:0042119) | 3.98089117 |
| 35 | ceramide catabolic process (GO:0046514) | 3.96679651 |
| 36 | pinocytosis (GO:0006907) | 3.94739628 |
| 37 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.89401299 |
| 38 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.80675201 |
| 39 | positive regulation of mast cell degranulation (GO:0043306) | 3.79081923 |
| 40 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.79081923 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.77451379 |
| 42 | response to host immune response (GO:0052572) | 3.77451379 |
| 43 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.76744483 |
| 44 | detection of molecule of bacterial origin (GO:0032490) | 3.75212660 |
| 45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.72187892 |
| 46 | regulation of hypersensitivity (GO:0002883) | 3.70356838 |
| 47 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.69360094 |
| 48 | T-helper 1 type immune response (GO:0042088) | 3.68888218 |
| 49 | regulation of mast cell degranulation (GO:0043304) | 3.68511914 |
| 50 | myeloid cell activation involved in immune response (GO:0002275) | 3.68121997 |
| 51 | monocyte chemotaxis (GO:0002548) | 3.67428016 |
| 52 | negative regulation of mast cell activation (GO:0033004) | 3.64634982 |
| 53 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.64046114 |
| 54 | positive regulation of mast cell activation (GO:0033005) | 3.62010903 |
| 55 | cellular response to type I interferon (GO:0071357) | 3.61500838 |
| 56 | type I interferon signaling pathway (GO:0060337) | 3.61500838 |
| 57 | lymphocyte chemotaxis (GO:0048247) | 3.60920809 |
| 58 | detection of other organism (GO:0098543) | 3.59181233 |
| 59 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.56730471 |
| 60 | response to type I interferon (GO:0034340) | 3.54972178 |
| 61 | response to thyroid hormone (GO:0097066) | 3.52244136 |
| 62 | positive regulation of interferon-beta production (GO:0032728) | 3.49723533 |
| 63 | positive regulation of lymphocyte migration (GO:2000403) | 3.46273552 |
| 64 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.44420810 |
| 65 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.42587497 |
| 66 | regulation of activation of Janus kinase activity (GO:0010533) | 3.42309618 |
| 67 | regulation of macrophage chemotaxis (GO:0010758) | 3.39857617 |
| 68 | N-acetylneuraminate metabolic process (GO:0006054) | 3.37882356 |
| 69 | defense response to protozoan (GO:0042832) | 3.37480408 |
| 70 | positive regulation of type 2 immune response (GO:0002830) | 3.30646144 |
| 71 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.30071241 |
| 72 | response to host (GO:0075136) | 3.30071241 |
| 73 | response to host defenses (GO:0052200) | 3.30071241 |
| 74 | phagocytosis, engulfment (GO:0006911) | 3.29612399 |
| 75 | regulation of mast cell activation (GO:0033003) | 3.28851872 |
| 76 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.25478714 |
| 77 | cellular extravasation (GO:0045123) | 3.25014648 |
| 78 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.24026170 |
| 79 | adhesion of symbiont to host cell (GO:0044650) | 3.22063693 |
| 80 | virion attachment to host cell (GO:0019062) | 3.22063693 |
| 81 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.21798583 |
| 82 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.21237252 |
| 83 | myeloid leukocyte activation (GO:0002274) | 3.20849296 |
| 84 | detection of bacterium (GO:0016045) | 3.20692058 |
| 85 | positive regulation of macrophage differentiation (GO:0045651) | 3.20064991 |
| 86 | positive regulation of macrophage cytokine production (GO:0060907) | 3.18334934 |
| 87 | response to interferon-alpha (GO:0035455) | 3.17367001 |
| 88 | membrane lipid catabolic process (GO:0046466) | 3.15077527 |
| 89 | cellular response to interferon-alpha (GO:0035457) | 3.14206340 |
| 90 | B cell mediated immunity (GO:0019724) | 3.13671634 |
| 91 | sphingolipid catabolic process (GO:0030149) | 3.10713304 |
| 92 | positive regulation of leukocyte degranulation (GO:0043302) | 3.08899102 |
| 93 | myeloid dendritic cell differentiation (GO:0043011) | 3.08195526 |
| 94 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.07537869 |
| 95 | detection of biotic stimulus (GO:0009595) | 3.06450732 |
| 96 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.05572585 |
| 97 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.05048176 |
| 98 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.04468533 |
| 99 | negative regulation of interleukin-17 production (GO:0032700) | 3.04384319 |
| 100 | response to protozoan (GO:0001562) | 3.03602037 |
| 101 | positive regulation of T cell migration (GO:2000406) | 3.03036889 |
| 102 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.02992318 |
| 103 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.00140157 |
| 104 | regulation of leukocyte degranulation (GO:0043300) | 2.98905324 |
| 105 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.96465358 |
| 106 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.96458239 |
| 107 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.93059146 |
| 108 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.90840122 |
| 109 | regulation of lymphocyte migration (GO:2000401) | 2.90343810 |
| 110 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.88193967 |
| 111 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.87792803 |
| 112 | myeloid dendritic cell activation (GO:0001773) | 2.87439532 |
| 113 | adhesion of symbiont to host (GO:0044406) | 2.87085343 |
| 114 | keratan sulfate catabolic process (GO:0042340) | 2.86528326 |
| 115 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.86325594 |
| 116 | T cell migration (GO:0072678) | 2.86128477 |
| 117 | regulation of cholesterol storage (GO:0010885) | 2.85871134 |
| 118 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.83831996 |
| 119 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.83381504 |
| 120 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.82989892 |
| 121 | response to muramyl dipeptide (GO:0032495) | 2.82523611 |
| 122 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.82231510 |
| 123 | cellular response to interferon-gamma (GO:0071346) | 2.82178153 |
| 124 | dendritic cell chemotaxis (GO:0002407) | 2.81849260 |
| 125 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.81722615 |
| 126 | mature B cell differentiation involved in immune response (GO:0002313) | 2.81132470 |
| 127 | regulation of RIG-I signaling pathway (GO:0039535) | 2.80785907 |
| 128 | barbed-end actin filament capping (GO:0051016) | 2.80268142 |
| 129 | detection of external biotic stimulus (GO:0098581) | 2.78772110 |
| 130 | regulation of podosome assembly (GO:0071801) | 2.78548828 |
| 131 | granulocyte chemotaxis (GO:0071621) | 2.78519938 |
| 132 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.78122946 |
| 133 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.76776333 |
| 134 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.76569313 |
| 135 | negative regulation of cell killing (GO:0031342) | 2.76081254 |
| 136 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.76081254 |
| 137 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.75575179 |
| 138 | regulation of chemokine biosynthetic process (GO:0045073) | 2.74908911 |
| 139 | positive regulation of regulated secretory pathway (GO:1903307) | 2.72521589 |
| 140 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.70370045 |
| 141 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.69134676 |
| 142 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.67886002 |
| 143 | positive regulation of acute inflammatory response (GO:0002675) | 2.67262827 |
| 144 | response to interferon-gamma (GO:0034341) | 2.66570981 |
| 145 | dendritic cell differentiation (GO:0097028) | 2.66355500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.98464799 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.51720547 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.60810098 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 5.03139368 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.54459907 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.29402068 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.07180558 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.88081616 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.57975436 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.48791725 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.87601196 |
| 12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.85427739 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.76349877 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.64461116 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57743106 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.50076257 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.38167108 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.20602804 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.09733157 |
| 20 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 2.06577456 |
| 21 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.01703355 |
| 22 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.00971205 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.92369880 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.91330540 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.79284583 |
| 26 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.76742703 |
| 27 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.71499101 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.68044066 |
| 29 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60437318 |
| 30 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.58917237 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58337286 |
| 32 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.58097627 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.57115626 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.54547850 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.52022980 |
| 36 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.49296275 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48428134 |
| 38 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.45537067 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41684761 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38221740 |
| 41 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36937038 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33551408 |
| 43 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.31861386 |
| 44 | MYB_26560356_Chip-Seq_TH2_Human | 1.31857691 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31335618 |
| 46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29721374 |
| 47 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22864145 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22673303 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21129453 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20142436 |
| 51 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17003015 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16462252 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14593072 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14348403 |
| 55 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13600877 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13151693 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.12110670 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11804330 |
| 59 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.11001274 |
| 60 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10446392 |
| 61 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.09880977 |
| 62 | MAF_26560356_Chip-Seq_TH1_Human | 1.09062959 |
| 63 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08231299 |
| 64 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07817921 |
| 65 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06134320 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05248604 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03403070 |
| 68 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.01731110 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01260753 |
| 70 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98708518 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96623346 |
| 72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96182304 |
| 73 | MYB_26560356_Chip-Seq_TH1_Human | 0.93058274 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90565197 |
| 75 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.89165028 |
| 76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89021161 |
| 77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87308709 |
| 78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87308709 |
| 79 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86935162 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86688419 |
| 81 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86330422 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.85940980 |
| 83 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.84739721 |
| 84 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.83695060 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83500877 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83320939 |
| 87 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83039172 |
| 88 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82876493 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82549697 |
| 90 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.82540353 |
| 91 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81148438 |
| 92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80755652 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79193139 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78566616 |
| 95 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.78246832 |
| 96 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.77349831 |
| 97 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.77303837 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77064707 |
| 99 | MAF_26560356_Chip-Seq_TH2_Human | 0.76895420 |
| 100 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.76409477 |
| 101 | CJUN_26792858_Chip-Seq_BT549_Human | 0.75379736 |
| 102 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.74601261 |
| 103 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.74556422 |
| 104 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.73848166 |
| 105 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.73638239 |
| 106 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.72946836 |
| 107 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.72031902 |
| 108 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.72008549 |
| 109 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.68762261 |
| 110 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66196052 |
| 111 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.63141555 |
| 112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.62980962 |
| 113 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.62149481 |
| 114 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61991572 |
| 115 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.59839343 |
| 116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.57862809 |
| 117 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.55914989 |
| 118 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55821236 |
| 119 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.55570850 |
| 120 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.54864256 |
| 121 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.52337622 |
| 122 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.51771021 |
| 123 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.50752201 |
| 124 | UTX_26944678_Chip-Seq_JUKART_Human | 0.49695594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.75948420 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 4.33063594 |
| 3 | MP0005058_abnormal_lysosome_morphology | 4.15479477 |
| 4 | MP0003436_decreased_susceptibility_to | 3.77972784 |
| 5 | MP0009840_abnormal_foam_cell | 3.64899152 |
| 6 | MP0009785_altered_susceptibility_to | 3.50923757 |
| 7 | MP0002419_abnormal_innate_immunity | 3.28648178 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.11155919 |
| 9 | MP0005671_abnormal_response_to | 3.01509764 |
| 10 | MP0005025_abnormal_response_to | 2.92910828 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.73432599 |
| 12 | MP0001790_abnormal_immune_system | 2.72889621 |
| 13 | MP0005387_immune_system_phenotype | 2.72889621 |
| 14 | MP0003724_increased_susceptibility_to | 2.72430471 |
| 15 | MP0006082_CNS_inflammation | 2.69051801 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.58796066 |
| 17 | MP0003303_peritoneal_inflammation | 2.50371155 |
| 18 | MP0001800_abnormal_humoral_immune | 2.46227098 |
| 19 | MP0002723_abnormal_immune_serum | 2.45133702 |
| 20 | MP0000685_abnormal_immune_system | 2.34343728 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 2.31182449 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.28709415 |
| 23 | MP0000343_altered_response_to | 2.26547608 |
| 24 | MP0000604_amyloidosis | 2.18271713 |
| 25 | MP0003690_abnormal_glial_cell | 2.09186580 |
| 26 | MP0001819_abnormal_immune_cell | 2.07196060 |
| 27 | MP0009764_decreased_sensitivity_to | 2.07057169 |
| 28 | MP0002420_abnormal_adaptive_immunity | 2.04674930 |
| 29 | MP0004510_myositis | 2.02312446 |
| 30 | MP0002405_respiratory_system_inflammati | 2.01917755 |
| 31 | MP0003075_altered_response_to | 1.97308927 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.92550553 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.85591051 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.80670005 |
| 35 | MP0001853_heart_inflammation | 1.79625194 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.77068651 |
| 37 | MP0002254_reproductive_system_inflammat | 1.72939339 |
| 38 | MP0008469_abnormal_protein_level | 1.71086133 |
| 39 | MP0003448_altered_tumor_morphology | 1.69091702 |
| 40 | MP0005310_abnormal_salivary_gland | 1.60678817 |
| 41 | MP0008004_abnormal_stomach_pH | 1.54695881 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.52876212 |
| 43 | MP0003828_pulmonary_edema | 1.51671546 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.51614006 |
| 45 | MP0008438_abnormal_cutaneous_collagen | 1.48522139 |
| 46 | MP0000716_abnormal_immune_system | 1.39030050 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.37795194 |
| 48 | MP0004947_skin_inflammation | 1.36991320 |
| 49 | MP0004782_abnormal_surfactant_physiolog | 1.36468410 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.35360704 |
| 51 | MP0005166_decreased_susceptibility_to | 1.31132244 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.29745069 |
| 53 | MP0005451_abnormal_body_composition | 1.29677505 |
| 54 | MP0005164_abnormal_response_to | 1.27113206 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.25359737 |
| 56 | MP0006054_spinal_hemorrhage | 1.24600946 |
| 57 | MP0002638_abnormal_pupillary_reflex | 1.22864990 |
| 58 | MP0003329_amyloid_beta_deposits | 1.20807258 |
| 59 | MP0002398_abnormal_bone_marrow | 1.16202400 |
| 60 | MP0005365_abnormal_bile_salt | 1.14033630 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.12503581 |
| 62 | MP0003279_aneurysm | 1.11013743 |
| 63 | MP0002006_tumorigenesis | 1.09914592 |
| 64 | MP0004883_abnormal_blood_vessel | 1.08121219 |
| 65 | MP0002429_abnormal_blood_cell | 1.07853128 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.05846490 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 1.05551004 |
| 68 | MP0005390_skeleton_phenotype | 1.02164293 |
| 69 | MP0008260_abnormal_autophagy | 1.00734359 |
| 70 | MP0002166_altered_tumor_susceptibility | 0.96195376 |
| 71 | MP0001542_abnormal_bone_strength | 0.96000851 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 0.95843067 |
| 73 | MP0000858_altered_metastatic_potential | 0.95113683 |
| 74 | MP0005174_abnormal_tail_pigmentation | 0.94690952 |
| 75 | MP0002722_abnormal_immune_system | 0.93829852 |
| 76 | MP0000015_abnormal_ear_pigmentation | 0.92442154 |
| 77 | MP0000249_abnormal_blood_vessel | 0.92325315 |
| 78 | MP0000920_abnormal_myelination | 0.90095300 |
| 79 | MP0009763_increased_sensitivity_to | 0.87074076 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 0.84705636 |
| 81 | MP0002295_abnormal_pulmonary_circulatio | 0.80843299 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 0.77391789 |
| 83 | MP0005647_abnormal_sex_gland | 0.75949958 |
| 84 | MP0003795_abnormal_bone_structure | 0.75590658 |
| 85 | MP0003186_abnormal_redox_activity | 0.75248302 |
| 86 | MP0010307_abnormal_tumor_latency | 0.72403731 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.72183764 |
| 88 | MP0003300_gastrointestinal_ulcer | 0.70940949 |
| 89 | MP0002933_joint_inflammation | 0.70640740 |
| 90 | MP0003705_abnormal_hypodermis_morpholog | 0.70430994 |
| 91 | MP0009278_abnormal_bone_marrow | 0.70019937 |
| 92 | MP0001663_abnormal_digestive_system | 0.68462381 |
| 93 | MP0003183_abnormal_peptide_metabolism | 0.67323427 |
| 94 | MP0002332_abnormal_exercise_endurance | 0.67092925 |
| 95 | MP0003091_abnormal_cell_migration | 0.66330600 |
| 96 | MP0003195_calcinosis | 0.65019121 |
| 97 | MP0001727_abnormal_embryo_implantation | 0.63097622 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.62122505 |
| 99 | MP0005165_increased_susceptibility_to | 0.61795485 |
| 100 | MP0003634_abnormal_glial_cell | 0.61664705 |
| 101 | MP0005257_abnormal_intraocular_pressure | 0.61339578 |
| 102 | MP0005275_abnormal_skin_tensile | 0.61278624 |
| 103 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.60689532 |
| 104 | MP0005319_abnormal_enzyme/_coenzyme | 0.60329830 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 0.58441861 |
| 106 | MP0008874_decreased_physiological_sensi | 0.56779126 |
| 107 | MP0004019_abnormal_vitamin_homeostasis | 0.55013919 |
| 108 | MP0000609_abnormal_liver_physiology | 0.54862981 |
| 109 | MP0003566_abnormal_cell_adhesion | 0.54722879 |
| 110 | MP0003633_abnormal_nervous_system | 0.54446802 |
| 111 | MP0008873_increased_physiological_sensi | 0.53900871 |
| 112 | MP0005595_abnormal_vascular_smooth | 0.53612112 |
| 113 | MP0009115_abnormal_fat_cell | 0.53497007 |
| 114 | MP0000371_diluted_coat_color | 0.51597918 |
| 115 | MP0005397_hematopoietic_system_phenotyp | 0.51565136 |
| 116 | MP0001545_abnormal_hematopoietic_system | 0.51565136 |
| 117 | MP0010368_abnormal_lymphatic_system | 0.49971712 |
| 118 | MP0005670_abnormal_white_adipose | 0.49898316 |
| 119 | MP0001851_eye_inflammation | 0.49808776 |
| 120 | MP0005076_abnormal_cell_differentiation | 0.49007070 |
| 121 | MP0003045_fibrosis | 0.48461581 |
| 122 | MP0002090_abnormal_vision | 0.48223682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.50155254 |
| 2 | Recurrent abscess formation (HP:0002722) | 7.47991195 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.82124837 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.84674344 |
| 5 | Glomerulonephritis (HP:0000099) | 5.82738727 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.02602395 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.95038674 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 4.48782136 |
| 9 | Autoimmune thrombocytopenia (HP:0001973) | 4.45305659 |
| 10 | Complement deficiency (HP:0004431) | 4.43883239 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.43110738 |
| 12 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.35497414 |
| 13 | Loss of speech (HP:0002371) | 4.35184263 |
| 14 | Axonal loss (HP:0003447) | 4.06752116 |
| 15 | Thick nail (HP:0001805) | 4.05971746 |
| 16 | Abnormality of complement system (HP:0005339) | 4.05921068 |
| 17 | Mutism (HP:0002300) | 4.04673157 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.98695886 |
| 19 | Disinhibition (HP:0000734) | 3.89781695 |
| 20 | Prostate neoplasm (HP:0100787) | 3.80701850 |
| 21 | Recurrent skin infections (HP:0001581) | 3.75869160 |
| 22 | Gingivitis (HP:0000230) | 3.68414685 |
| 23 | Myositis (HP:0100614) | 3.68038096 |
| 24 | Dysostosis multiplex (HP:0000943) | 3.59357495 |
| 25 | Orchitis (HP:0100796) | 3.55497215 |
| 26 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.45082838 |
| 27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.45030583 |
| 28 | Nephritis (HP:0000123) | 3.44247622 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.40786815 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.40786815 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 3.40786815 |
| 32 | Spontaneous hematomas (HP:0007420) | 3.37514597 |
| 33 | Pustule (HP:0200039) | 3.37310914 |
| 34 | Optic neuritis (HP:0100653) | 3.31242567 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 3.31242567 |
| 36 | Nuclear cataract (HP:0100018) | 3.13597988 |
| 37 | Agnosia (HP:0010524) | 3.12700231 |
| 38 | Stomatitis (HP:0010280) | 3.11194593 |
| 39 | Obstructive lung disease (HP:0006536) | 3.09629452 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 3.09629452 |
| 41 | Amyloidosis (HP:0011034) | 3.00733677 |
| 42 | Basal ganglia calcification (HP:0002135) | 3.00348971 |
| 43 | Recurrent fungal infections (HP:0002841) | 2.99761835 |
| 44 | Recurrent viral infections (HP:0004429) | 2.93263007 |
| 45 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.89803628 |
| 46 | Osteolytic defects of the hand bones (HP:0009699) | 2.89803628 |
| 47 | Periodontitis (HP:0000704) | 2.89765764 |
| 48 | Neurofibrillary tangles (HP:0002185) | 2.87850713 |
| 49 | Increased IgM level (HP:0003496) | 2.87807650 |
| 50 | Myocardial infarction (HP:0001658) | 2.83293776 |
| 51 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.73713734 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.69606893 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.61360136 |
| 54 | Hematochezia (HP:0002573) | 2.60644349 |
| 55 | Increased serum ferritin (HP:0003281) | 2.58996876 |
| 56 | Petechiae (HP:0000967) | 2.56007143 |
| 57 | Upper motor neuron abnormality (HP:0002127) | 2.53791476 |
| 58 | Joint hemorrhage (HP:0005261) | 2.51447949 |
| 59 | Neuronal loss in central nervous system (HP:0002529) | 2.51023129 |
| 60 | Vasculitis (HP:0002633) | 2.45860462 |
| 61 | Progressive visual loss (HP:0000529) | 2.45748353 |
| 62 | Progressive neurologic deterioration (HP:0002344) | 2.42876602 |
| 63 | Pathologic fracture (HP:0002756) | 2.40622616 |
| 64 | Cellulitis (HP:0100658) | 2.39079855 |
| 65 | Recurrent pneumonia (HP:0006532) | 2.36831315 |
| 66 | Urticaria (HP:0001025) | 2.34753914 |
| 67 | Hypergammaglobulinemia (HP:0010702) | 2.33157932 |
| 68 | Mucopolysacchariduria (HP:0008155) | 2.30377155 |
| 69 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.30377155 |
| 70 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.30007959 |
| 71 | Leukocytosis (HP:0001974) | 2.26539163 |
| 72 | Hypokinesia (HP:0002375) | 2.22056659 |
| 73 | Thyroiditis (HP:0100646) | 2.21648806 |
| 74 | Hepatosplenomegaly (HP:0001433) | 2.21038536 |
| 75 | Keratoconjunctivitis sicca (HP:0001097) | 2.20365311 |
| 76 | Osteomyelitis (HP:0002754) | 2.20142690 |
| 77 | Personality changes (HP:0000751) | 2.20089494 |
| 78 | Bone pain (HP:0002653) | 2.19883426 |
| 79 | Hemoptysis (HP:0002105) | 2.18942827 |
| 80 | Abnormality of the prostate (HP:0008775) | 2.17464809 |
| 81 | Abnormality of iron homeostasis (HP:0011031) | 2.16409747 |
| 82 | Combined immunodeficiency (HP:0005387) | 2.16324980 |
| 83 | Polyneuropathy (HP:0001271) | 2.16226720 |
| 84 | Colitis (HP:0002583) | 2.15434484 |
| 85 | Abnormality of the periventricular white matter (HP:0002518) | 2.13373685 |
| 86 | Retinal atrophy (HP:0001105) | 2.12848851 |
| 87 | Dementia (HP:0000726) | 2.12137698 |
| 88 | Meningitis (HP:0001287) | 2.11949365 |
| 89 | Eosinophilia (HP:0001880) | 2.10830109 |
| 90 | Purpura (HP:0000979) | 2.09908363 |
| 91 | Asymmetric septal hypertrophy (HP:0001670) | 2.08855858 |
| 92 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08275176 |
| 93 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08275176 |
| 94 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08275176 |
| 95 | Vertebral compression fractures (HP:0002953) | 2.07884855 |
| 96 | Prolonged neonatal jaundice (HP:0006579) | 2.05933355 |
| 97 | Metaphyseal irregularity (HP:0003025) | 2.05822429 |
| 98 | Inappropriate behavior (HP:0000719) | 2.03690185 |
| 99 | Cerebral inclusion bodies (HP:0100314) | 2.03034243 |
| 100 | Poor head control (HP:0002421) | 2.01903568 |
| 101 | Conjunctival telangiectasia (HP:0000524) | 2.01747916 |
| 102 | Tetraparesis (HP:0002273) | 2.01103755 |
| 103 | Premature loss of primary teeth (HP:0006323) | 1.99782036 |
| 104 | Arterial thrombosis (HP:0004420) | 1.98780052 |
| 105 | Keratoconjunctivitis (HP:0001096) | 1.98736601 |
| 106 | Recurrent lower respiratory tract infections (HP:0002783) | 1.96248956 |
| 107 | Apathy (HP:0000741) | 1.94415584 |
| 108 | Nausea (HP:0002018) | 1.92329459 |
| 109 | Peripheral demyelination (HP:0011096) | 1.90431497 |
| 110 | Memory impairment (HP:0002354) | 1.88998860 |
| 111 | Cardiomegaly (HP:0001640) | 1.87990259 |
| 112 | Global brain atrophy (HP:0002283) | 1.87654566 |
| 113 | Increased CSF protein (HP:0002922) | 1.87053655 |
| 114 | T lymphocytopenia (HP:0005403) | 1.86563554 |
| 115 | Diminished motivation (HP:0000745) | 1.84411406 |
| 116 | Malnutrition (HP:0004395) | 1.83539034 |
| 117 | Inflammation of the large intestine (HP:0002037) | 1.81687233 |
| 118 | Spinal muscular atrophy (HP:0007269) | 1.81647256 |
| 119 | Gingival bleeding (HP:0000225) | 1.81143052 |
| 120 | Pulmonary embolism (HP:0002204) | 1.80982038 |
| 121 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.80793915 |
| 122 | Recurrent cutaneous fungal infections (HP:0011370) | 1.80793915 |
| 123 | Supranuclear gaze palsy (HP:0000605) | 1.80649404 |
| 124 | Abnormality of T cell number (HP:0011839) | 1.78392312 |
| 125 | Thoracic kyphosis (HP:0002942) | 1.78065811 |
| 126 | Sepsis (HP:0100806) | 1.75632537 |
| 127 | Chronic otitis media (HP:0000389) | 1.74950711 |
| 128 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.74378257 |
| 129 | Gangrene (HP:0100758) | 1.72951819 |
| 130 | Beaking of vertebral bodies (HP:0004568) | 1.68663212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 5.90609384 |
| 2 | MAP3K14 | 4.94432221 |
| 3 | TYK2 | 4.23588802 |
| 4 | RIPK4 | 3.29679285 |
| 5 | TBK1 | 3.22143470 |
| 6 | IRAK4 | 2.93619677 |
| 7 | NME2 | 2.92915450 |
| 8 | MST4 | 2.61007398 |
| 9 | GRK7 | 2.55769357 |
| 10 | TGFBR2 | 2.51289380 |
| 11 | IKBKE | 2.38636001 |
| 12 | IKBKB | 2.37728531 |
| 13 | IRAK3 | 2.23681676 |
| 14 | TXK | 2.22254232 |
| 15 | PBK | 2.19610154 |
| 16 | JAK1 | 2.01637862 |
| 17 | DDR2 | 1.96777218 |
| 18 | TAOK2 | 1.77370531 |
| 19 | ZAP70 | 1.76405708 |
| 20 | KIT | 1.75533498 |
| 21 | ERN1 | 1.71569349 |
| 22 | MAP3K3 | 1.70136293 |
| 23 | BMPR2 | 1.69455578 |
| 24 | ACVR1B | 1.68082765 |
| 25 | MAP2K3 | 1.65945344 |
| 26 | FGR | 1.65614527 |
| 27 | EPHB1 | 1.61478416 |
| 28 | CSK | 1.55673291 |
| 29 | JAK3 | 1.54871536 |
| 30 | CLK1 | 1.54582173 |
| 31 | RIPK1 | 1.51600502 |
| 32 | MAP3K11 | 1.51109436 |
| 33 | MAP4K1 | 1.49353817 |
| 34 | CHUK | 1.47773075 |
| 35 | LYN | 1.46190422 |
| 36 | SYK | 1.43080393 |
| 37 | HCK | 1.41418517 |
| 38 | PIM2 | 1.33267599 |
| 39 | NEK9 | 1.29158269 |
| 40 | TAOK1 | 1.26580423 |
| 41 | STK10 | 1.25538056 |
| 42 | CSF1R | 1.23788464 |
| 43 | EIF2AK2 | 1.23088913 |
| 44 | BMX | 1.20457848 |
| 45 | BTK | 1.20183734 |
| 46 | TEC | 1.16116668 |
| 47 | JAK2 | 1.15020516 |
| 48 | MAP3K13 | 1.14993457 |
| 49 | FES | 1.10925425 |
| 50 | PDK2 | 1.10789573 |
| 51 | LCK | 1.08835235 |
| 52 | CDC42BPA | 1.06226643 |
| 53 | ADRBK2 | 1.01308544 |
| 54 | TAOK3 | 0.99934906 |
| 55 | MAP3K1 | 0.99436654 |
| 56 | MATK | 0.96062730 |
| 57 | BMPR1B | 0.95170048 |
| 58 | MOS | 0.95085107 |
| 59 | PRKCD | 0.91686158 |
| 60 | ITK | 0.86104338 |
| 61 | PIM1 | 0.84511438 |
| 62 | TESK2 | 0.82796523 |
| 63 | EGFR | 0.81540561 |
| 64 | YES1 | 0.80126161 |
| 65 | FGFR3 | 0.78457933 |
| 66 | ERBB3 | 0.73888928 |
| 67 | MAP3K5 | 0.72290352 |
| 68 | PDPK1 | 0.67709341 |
| 69 | TRPM7 | 0.66533445 |
| 70 | MAP2K6 | 0.60892772 |
| 71 | SCYL2 | 0.57466392 |
| 72 | PIK3CG | 0.56891240 |
| 73 | NUAK1 | 0.55104144 |
| 74 | MAPK12 | 0.54879576 |
| 75 | MAPKAPK2 | 0.53491127 |
| 76 | FGFR4 | 0.53471648 |
| 77 | ABL2 | 0.53087924 |
| 78 | MAP3K6 | 0.52646685 |
| 79 | ARAF | 0.51595761 |
| 80 | PRKCQ | 0.51468099 |
| 81 | DAPK2 | 0.50488004 |
| 82 | IGF1R | 0.50438107 |
| 83 | ABL1 | 0.49806013 |
| 84 | FYN | 0.48813580 |
| 85 | IRAK1 | 0.47587781 |
| 86 | PRPF4B | 0.44682430 |
| 87 | PLK2 | 0.44179418 |
| 88 | CDK6 | 0.43861237 |
| 89 | TESK1 | 0.43737098 |
| 90 | STK4 | 0.43487328 |
| 91 | PTK2B | 0.40024599 |
| 92 | EPHA3 | 0.39589449 |
| 93 | PTK6 | 0.38156727 |
| 94 | MARK3 | 0.37597493 |
| 95 | IRAK2 | 0.37437746 |
| 96 | GRK5 | 0.36775231 |
| 97 | RPS6KA2 | 0.36711415 |
| 98 | CAMK1G | 0.34636328 |
| 99 | TGFBR1 | 0.34545871 |
| 100 | PDGFRA | 0.33448466 |
| 101 | PKN1 | 0.31056242 |
| 102 | CAMKK2 | 0.29780062 |
| 103 | INSR | 0.29513737 |
| 104 | MET | 0.28157013 |
| 105 | SIK2 | 0.27512576 |
| 106 | GSK3A | 0.26879441 |
| 107 | RPS6KA6 | 0.25964133 |
| 108 | KSR2 | 0.23663234 |
| 109 | PRKD1 | 0.23649156 |
| 110 | PDGFRB | 0.23368938 |
| 111 | DMPK | 0.23157207 |
| 112 | PAK4 | 0.22855031 |
| 113 | PRKACG | 0.21663097 |
| 114 | GRK6 | 0.21598524 |
| 115 | PDK1 | 0.21100426 |
| 116 | CAMK1D | 0.21080179 |
| 117 | SRC | 0.20980913 |
| 118 | RPS6KL1 | 0.20964089 |
| 119 | RPS6KC1 | 0.20964089 |
| 120 | MAPK4 | 0.20460828 |
| 121 | CAMKK1 | 0.19605122 |
| 122 | HIPK2 | 0.19411859 |
| 123 | MAP3K12 | 0.19280746 |
| 124 | MAPK7 | 0.16956877 |
| 125 | TNK2 | 0.15866087 |
| 126 | PRKCG | 0.14874305 |
| 127 | MAPK3 | 0.14518308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.89470441 |
| 2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.88801351 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 2.87384881 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.86937049 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.84974873 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.71075309 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.59433031 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44440121 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 2.36567748 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.27662802 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.25821051 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.21614676 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.17580697 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.13802359 |
| 15 | Malaria_Homo sapiens_hsa05144 | 2.13362779 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 2.12774449 |
| 17 | Asthma_Homo sapiens_hsa05310 | 2.06062452 |
| 18 | Phagosome_Homo sapiens_hsa04145 | 1.91329432 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.88436312 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.83698679 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.81166533 |
| 22 | Salmonella infection_Homo sapiens_hsa05132 | 1.80282128 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.79215324 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.76844426 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.67585346 |
| 26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.60597768 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.60523600 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.57167351 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.57008885 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.54055686 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.52916705 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.50848264 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43560170 |
| 34 | Prion diseases_Homo sapiens_hsa05020 | 1.41390377 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.41272002 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.37542815 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.32584607 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27874124 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27821390 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.26201953 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.24529811 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20617434 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.18688637 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.15583226 |
| 45 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.13466105 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08287718 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05019440 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00142619 |
| 49 | Mineral absorption_Homo sapiens_hsa04978 | 0.99979583 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.95710802 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83343683 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83162728 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82927230 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.81945082 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79082404 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 0.78000771 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.75241589 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71702805 |
| 59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.68746510 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67216284 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.66261071 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66223625 |
| 63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63794826 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.59970841 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58102515 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57998563 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52868755 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52616948 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51602680 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 0.47135070 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46499079 |
| 72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45002368 |
| 73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.44577207 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44042031 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43790291 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.42951326 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39930824 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.33025514 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.31701980 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29581371 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29563701 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29307871 |
| 83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.23547266 |
| 84 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.22648307 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22607285 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22456101 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.21937593 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.21523015 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21467406 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.21240412 |
| 91 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.20094521 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18934546 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18796098 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.18191182 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.17994400 |
| 96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.17070199 |
| 97 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.16968597 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16036581 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.12614830 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.12573433 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.12036627 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.11206927 |
| 103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.10624309 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.10039008 |
| 105 | Histidine metabolism_Homo sapiens_hsa00340 | 0.09684611 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.09589827 |
| 107 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.09145985 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.08741548 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.08580383 |
| 110 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.08417540 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.08316469 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.08022801 |
| 113 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.07403621 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.05315482 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.05044266 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.04000989 |
| 117 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.01894789 |

